Apple Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Apple Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Sep 29, 2018 | $62.90B | Nov 5, 2018 |
| FY2018 | Jun 30, 2018 | $53.27B | Nov 5, 2018 |
| FY2018 | Mar 31, 2018 | $61.14B | Nov 5, 2018 |
| FY2018 | Dec 30, 2017 | $88.29B | Nov 5, 2018 |
| FY2018 | Sep 30, 2017 | $52.58B | Nov 5, 2018 |
| FY2018 | Jul 1, 2017 | $45.41B | Nov 5, 2018 |
| FY2018 | Apr 1, 2017 | $52.90B | Nov 5, 2018 |
| FY2018 | Dec 31, 2016 | $78.35B | Nov 5, 2018 |
| FY2018 | Sep 24, 2016 | $215.64B | Nov 5, 2018 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 27, 2025 | $416.16B | Oct 31, 2025 |
| FY2025 | Sep 28, 2024 | $391.04B | Oct 31, 2025 |
| FY2025 | Sep 30, 2023 | $383.29B | Oct 31, 2025 |
| FY2024 | Sep 24, 2022 | $394.33B | Nov 1, 2024 |
| FY2023 | Sep 25, 2021 | $365.82B | Nov 3, 2023 |
| FY2020 | Sep 26, 2020 | $64.70B | Oct 30, 2020 |
| FY2020 | Jun 27, 2020 | $59.69B | Oct 30, 2020 |
| FY2020 | Mar 28, 2020 | $58.31B | Oct 30, 2020 |
| FY2020 | Dec 28, 2019 | $91.82B | Oct 30, 2020 |
| FY2020 | Sep 28, 2019 | $64.04B | Oct 30, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Sep 30, 2017 | $52.58B | Nov 3, 2017 |
| FY2017 | Jul 1, 2017 | $45.41B | Nov 3, 2017 |
| FY2017 | Apr 1, 2017 | $52.90B | Nov 3, 2017 |
| FY2017 | Dec 31, 2016 | $78.35B | Nov 3, 2017 |
| FY2017 | Sep 24, 2016 | $46.85B | Nov 3, 2017 |
| FY2017 | Jun 25, 2016 | $42.36B | Nov 3, 2017 |
| FY2017 | Mar 26, 2016 | $50.56B | Nov 3, 2017 |
| FY2017 | Dec 26, 2015 | $75.87B | Nov 3, 2017 |
| FY2016 | Sep 26, 2015 | $51.50B | Oct 26, 2016 |
| FY2016 | Jun 27, 2015 | $49.61B | Oct 26, 2016 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 27, 2025 | $195.20B | Oct 31, 2025 |
| FY2025 | Sep 28, 2024 | $180.68B | Oct 31, 2025 |
| FY2025 | Sep 30, 2023 | $169.15B | Oct 31, 2025 |
| FY2024 | Sep 24, 2022 | $170.78B | Nov 1, 2024 |
| FY2023 | Sep 25, 2021 | $152.84B | Nov 3, 2023 |
| FY2020 | Sep 26, 2020 | $24.69B | Oct 30, 2020 |
| FY2020 | Jun 27, 2020 | $22.68B | Oct 30, 2020 |
| FY2020 | Mar 28, 2020 | $22.37B | Oct 30, 2020 |
| FY2020 | Dec 28, 2019 | $35.22B | Oct 30, 2020 |
| FY2020 | Sep 28, 2019 | $24.31B | Oct 30, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 27, 2025 | $112.01B | Oct 31, 2025 |
| FY2025 | Sep 28, 2024 | $93.74B | Oct 31, 2025 |
| FY2025 | Sep 30, 2023 | $97.00B | Oct 31, 2025 |
| FY2024 | Sep 24, 2022 | $99.80B | Nov 1, 2024 |
| FY2023 | Sep 25, 2021 | $94.68B | Nov 3, 2023 |
| FY2020 | Sep 26, 2020 | $12.67B | Oct 30, 2020 |
| FY2020 | Jun 27, 2020 | $11.25B | Oct 30, 2020 |
| FY2020 | Mar 28, 2020 | $11.25B | Oct 30, 2020 |
| FY2020 | Dec 28, 2019 | $22.24B | Oct 30, 2020 |
| FY2020 | Sep 28, 2019 | $13.69B | Oct 30, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 27, 2025 | $133.05B | Oct 31, 2025 |
| FY2025 | Sep 28, 2024 | $123.22B | Oct 31, 2025 |
| FY2025 | Sep 30, 2023 | $114.30B | Oct 31, 2025 |
| FY2024 | Sep 24, 2022 | $119.44B | Nov 1, 2024 |
| FY2023 | Sep 25, 2021 | $108.95B | Nov 3, 2023 |
| FY2022 | Sep 26, 2020 | $66.29B | Oct 28, 2022 |
| FY2021 | Sep 28, 2019 | $63.93B | Oct 29, 2021 |
| FY2020 | Sep 29, 2018 | $70.90B | Oct 30, 2020 |
| FY2019 | Sep 30, 2017 | $61.34B | Oct 31, 2019 |
| FY2018 | Sep 24, 2016 | $60.02B | Nov 5, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 27, 2025 | $34.55B | Oct 31, 2025 |
| FY2025 | Sep 28, 2024 | $31.37B | Oct 31, 2025 |
| FY2025 | Sep 30, 2023 | $29.92B | Oct 31, 2025 |
| FY2024 | Sep 24, 2022 | $26.25B | Nov 1, 2024 |
| FY2023 | Sep 25, 2021 | $21.91B | Nov 3, 2023 |
| FY2022 | Sep 26, 2020 | $18.75B | Oct 28, 2022 |
| FY2021 | Sep 28, 2019 | $16.22B | Oct 29, 2021 |
| FY2020 | Sep 29, 2018 | $14.24B | Oct 30, 2020 |
| FY2019 | Sep 30, 2017 | $11.58B | Oct 31, 2019 |
| FY2018 | Sep 24, 2016 | $10.05B | Nov 5, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 27, 2025 | $27.60B | Oct 31, 2025 |
| FY2025 | Sep 28, 2024 | $26.10B | Oct 31, 2025 |
| FY2025 | Sep 30, 2023 | $24.93B | Oct 31, 2025 |
| FY2024 | Sep 24, 2022 | $25.09B | Nov 1, 2024 |
| FY2023 | Sep 25, 2021 | $21.97B | Nov 3, 2023 |
| FY2022 | Sep 26, 2020 | $19.92B | Oct 28, 2022 |
| FY2021 | Sep 28, 2019 | $18.25B | Oct 29, 2021 |
| FY2020 | Sep 29, 2018 | $16.71B | Oct 30, 2020 |
| FY2019 | Sep 30, 2017 | $15.26B | Oct 31, 2019 |
| FY2018 | Sep 24, 2016 | $14.19B | Nov 5, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 27, 2025 | $111.48B | Oct 31, 2025 |
| FY2025 | Sep 28, 2024 | $118.25B | Oct 31, 2025 |
| FY2025 | Sep 30, 2023 | $110.54B | Oct 31, 2025 |
| FY2024 | Sep 24, 2022 | $122.15B | Nov 1, 2024 |
| FY2023 | Sep 25, 2021 | $104.04B | Nov 3, 2023 |
| FY2022 | Sep 26, 2020 | $80.67B | Oct 28, 2022 |
| FY2021 | Sep 28, 2019 | $69.39B | Oct 29, 2021 |
| FY2020 | Sep 29, 2018 | $77.43B | Oct 30, 2020 |
| FY2019 | Sep 30, 2017 | $64.23B | Oct 31, 2019 |
| FY2018 | Sep 24, 2016 | $66.23B | Nov 5, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 27, 2025 | $12.72B | Oct 31, 2025 |
| FY2025 | Sep 28, 2024 | $9.45B | Oct 31, 2025 |
| FY2025 | Sep 30, 2023 | $10.96B | Oct 31, 2025 |
| FY2024 | Sep 24, 2022 | $10.71B | Nov 1, 2024 |
| FY2023 | Sep 25, 2021 | $11.09B | Nov 3, 2023 |
| FY2022 | Sep 26, 2020 | $7.31B | Oct 28, 2022 |
| FY2021 | Sep 28, 2019 | $10.50B | Oct 29, 2021 |
| FY2020 | Sep 29, 2018 | $13.31B | Oct 30, 2020 |
| FY2019 | Sep 30, 2017 | $12.45B | Oct 31, 2019 |
| FY2018 | Sep 24, 2016 | $12.73B | Nov 5, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 27, 2025 | $359.24B | Oct 31, 2025 |
| FY2025 | Sep 28, 2024 | $364.98B | Oct 31, 2025 |
| FY2024 | Sep 30, 2023 | $352.58B | Nov 1, 2024 |
| FY2023 | Sep 24, 2022 | $352.76B | Nov 3, 2023 |
| FY2022 | Sep 25, 2021 | $351.00B | Oct 28, 2022 |
| FY2021 | Sep 26, 2020 | $323.89B | Oct 29, 2021 |
| FY2020 | Sep 28, 2019 | $338.52B | Oct 30, 2020 |
| FY2019 | Sep 29, 2018 | $365.73B | Oct 31, 2019 |
| FY2018 | Sep 30, 2017 | $375.32B | Nov 5, 2018 |
| FY2017 | Sep 24, 2016 | $321.69B | Nov 3, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 27, 2025 | $285.51B | Oct 31, 2025 |
| FY2025 | Sep 28, 2024 | $308.03B | Oct 31, 2025 |
| FY2024 | Sep 30, 2023 | $290.44B | Nov 1, 2024 |
| FY2023 | Sep 24, 2022 | $302.08B | Nov 3, 2023 |
| FY2022 | Sep 25, 2021 | $287.91B | Oct 28, 2022 |
| FY2021 | Sep 26, 2020 | $258.55B | Oct 29, 2021 |
| FY2020 | Sep 28, 2019 | $248.03B | Oct 30, 2020 |
| FY2019 | Sep 29, 2018 | $258.58B | Oct 31, 2019 |
| FY2018 | Sep 30, 2017 | $241.27B | Nov 5, 2018 |
| FY2017 | Sep 24, 2016 | $193.44B | Nov 3, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 27, 2025 | $73.73B | Oct 31, 2025 |
| FY2025 | Sep 28, 2024 | $56.95B | Oct 31, 2025 |
| FY2025 | Sep 30, 2023 | $62.15B | Oct 31, 2025 |
| FY2025 | Sep 24, 2022 | $50.67B | Oct 31, 2025 |
| FY2024 | Sep 25, 2021 | $63.09B | Nov 1, 2024 |
| FY2023 | Sep 26, 2020 | $65.34B | Nov 3, 2023 |
| FY2022 | Sep 28, 2019 | $90.49B | Oct 28, 2022 |
| FY2021 | Sep 29, 2018 | $107.15B | Oct 29, 2021 |
| FY2020 | Sep 30, 2017 | $134.05B | Oct 30, 2020 |
| FY2019 | Sep 24, 2016 | $128.25B | Oct 31, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Sep 30, 2017 | $5.72B | Nov 3, 2017 |
| FY2017 | Sep 24, 2016 | $5.41B | Nov 3, 2017 |
| FY2016 | Sep 26, 2015 | $5.12B | Oct 26, 2016 |
| FY2015 | Sep 27, 2014 | $4.62B | Oct 28, 2015 |
| FY2014 | Sep 28, 2013 | $1.58B | Oct 27, 2014 |
| FY2013 | Sep 29, 2012 | $1.14B | Oct 30, 2013 |
| FY2012 | Sep 24, 2011 | $896.00M | Oct 31, 2012 |
| FY2011 | Sep 25, 2010 | $741.00M | Oct 26, 2011 |
| FY2010 | Sep 26, 2009 | $206.00M | Oct 27, 2010 |
| FY2009 | Sep 27, 2008 | $207.00M | Jan 25, 2010 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 27, 2025 | ($14.26B) | Oct 31, 2025 |
| FY2025 | Sep 28, 2024 | ($19.15B) | Oct 31, 2025 |
| FY2024 | Sep 30, 2023 | ($214.00M) | Nov 1, 2024 |
| FY2023 | Sep 24, 2022 | ($3.07B) | Nov 3, 2023 |
| FY2022 | Sep 25, 2021 | $5.56B | Oct 28, 2022 |
| FY2021 | Sep 26, 2020 | $14.97B | Oct 29, 2021 |
| FY2020 | Sep 28, 2019 | $45.90B | Oct 30, 2020 |
| FY2019 | Sep 29, 2018 | $70.40B | Oct 31, 2019 |
| FY2018 | Sep 30, 2017 | $98.33B | Nov 5, 2018 |
| FY2017 | Sep 24, 2016 | $96.36B | Nov 3, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 27, 2025 | $35.93B | Oct 31, 2025 |
| FY2025 | Sep 28, 2024 | $29.94B | Oct 31, 2025 |
| FY2024 | Sep 30, 2023 | $29.97B | Nov 1, 2024 |
| FY2023 | Sep 24, 2022 | $23.65B | Nov 3, 2023 |
| FY2022 | Sep 25, 2021 | $34.94B | Oct 28, 2022 |
| FY2021 | Sep 26, 2020 | $38.02B | Oct 29, 2021 |
| FY2020 | Sep 28, 2019 | $48.84B | Oct 30, 2020 |
| FY2019 | Sep 29, 2018 | $25.91B | Oct 31, 2019 |
| FY2018 | Sep 30, 2017 | $20.29B | Nov 5, 2018 |
| FY2018 | Sep 24, 2016 | $20.48B | Nov 5, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 27, 2025 | $90.68B | Oct 31, 2025 |
| FY2025 | Sep 28, 2024 | $96.66B | Oct 31, 2025 |
| FY2024 | Sep 30, 2023 | $105.10B | Nov 1, 2024 |
| FY2023 | Sep 24, 2022 | $110.09B | Nov 3, 2023 |
| FY2014 | Sep 27, 2014 | $28.99B | Oct 27, 2014 |
| FY2014 | Sep 28, 2013 | $16.96B | Oct 27, 2014 |
| FY2013 | Sep 29, 2012 | $0 | Oct 30, 2013 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 27, 2025 | 7 | Oct 31, 2025 |
| FY2025 | Sep 28, 2024 | 6 | Oct 31, 2025 |
| FY2025 | Sep 30, 2023 | 6 | Oct 31, 2025 |
| FY2024 | Sep 24, 2022 | 6 | Nov 1, 2024 |
| FY2023 | Sep 25, 2021 | 5 | Nov 3, 2023 |
| FY2020 | Sep 26, 2020 | 0 | Oct 30, 2020 |
| FY2020 | Jun 27, 2020 | 0 | Oct 30, 2020 |
| FY2020 | Mar 28, 2020 | 0 | Oct 30, 2020 |
| FY2020 | Dec 28, 2019 | 1 | Oct 30, 2020 |
| FY2020 | Sep 28, 2019 | 0 | Oct 30, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 27, 2025 | 7 | Oct 31, 2025 |
| FY2025 | Sep 28, 2024 | 6 | Oct 31, 2025 |
| FY2025 | Sep 30, 2023 | 6 | Oct 31, 2025 |
| FY2024 | Sep 24, 2022 | 6 | Nov 1, 2024 |
| FY2023 | Sep 25, 2021 | 5 | Nov 3, 2023 |
| FY2020 | Sep 26, 2020 | 0 | Oct 30, 2020 |
| FY2020 | Jun 27, 2020 | 0 | Oct 30, 2020 |
| FY2020 | Mar 28, 2020 | 0 | Oct 30, 2020 |
| FY2020 | Dec 28, 2019 | 1 | Oct 30, 2020 |
| FY2020 | Sep 28, 2019 | 0 | Oct 30, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 27, 2025 | 14.77B | Oct 31, 2025 |
| FY2025 | Sep 28, 2024 | 15.12B | Oct 31, 2025 |
| FY2024 | Sep 30, 2023 | 15.55B | Nov 1, 2024 |
| FY2023 | Sep 24, 2022 | 15.94B | Nov 3, 2023 |
| FY2022 | Sep 25, 2021 | 16.43B | Oct 28, 2022 |
| FY2021 | Sep 26, 2020 | 16.98B | Oct 29, 2021 |
| FY2020 | Sep 28, 2019 | 17.77B | Oct 30, 2020 |
| FY2019 | Sep 29, 2018 | 4.75B | Oct 31, 2019 |
| FY2018 | Sep 30, 2017 | 5.13B | Nov 5, 2018 |
| FY2017 | Sep 24, 2016 | 5.34B | Nov 3, 2017 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Sep 30, 2017 | $3.25B | Nov 3, 2017 |
| FY2017 | Jul 1, 2017 | $3.28B | Nov 3, 2017 |
| FY2017 | Apr 1, 2017 | $2.99B | Nov 3, 2017 |
| FY2017 | Dec 31, 2016 | $3.04B | Nov 3, 2017 |
| FY2017 | Sep 24, 2016 | $3.07B | Nov 3, 2017 |
| FY2017 | Jun 25, 2016 | $3.12B | Nov 3, 2017 |
| FY2017 | Mar 26, 2016 | $2.88B | Nov 3, 2017 |
| FY2017 | Dec 26, 2015 | $2.90B | Nov 3, 2017 |